RecruitingNCT04483804

Application of Radiomics in Breast Cancer

Application of Radiomics in Correlation Between Ultrasound Characteristics and Pathological Prognostic Factors in Breast Cancer


Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment

2,000 participants

Start Date

Jan 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study uses a technology called radiomics — which extracts detailed patterns and measurements from medical images like MRI or CT scans — to better understand and predict outcomes in breast cancer. The goal is to develop imaging-based tools that can help guide treatment decisions. **You may be eligible if...** - You have a clinical diagnosis of breast cancer - You have had or will have medical imaging (such as an MRI, CT, or mammogram) as part of your care **You may NOT be eligible if...** - You do not have a breast cancer diagnosis - You are unwilling to share imaging data for research purposes Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTEndocrine therapy

Endocrine therapy


Locations(1)

the Second Affiliated Hospital Zhejiang University School of Medicine

Hanzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04483804


Related Trials